The Developmental Trajectory and Correlation of Human Milk Microbiota and Oligosaccharides in Taiwanese Lactating Mothers
- PMID: 40814727
- DOI: 10.1111/1750-3841.70484
The Developmental Trajectory and Correlation of Human Milk Microbiota and Oligosaccharides in Taiwanese Lactating Mothers
Abstract
Human milk microbiota (HMM) and human milk oligosaccharides (HMOs) are crucial components of breast milk that influence infant health and development. This study provides long-term insights into the dynamic changes in HMM and HMOs and their interactions among Taiwanese lactating mothers. A cohort of 90 mothers with singleton, full-term infants contributed 319 breast milk samples across eight lactation stages over 52 weeks. HMOs were quantified using mass spectrometry, while milk microbiota composition was analyzed through 16S rRNA sequencing. Our findings reveal that HMO concentrations steadily declined from birth to 52 weeks postpartum. The most abundant HMO was 2'-fucosyllactose (2'-FL, 18.8%), followed by 3-fucosyllactose (3-FL, 16.5%). Notably, 2'-FL levels decreased over time, while 3-FL concentrations increased. Other HMOs exhibited a general downward trend throughout lactation. HMM composition also shifted dynamically, with significant variations in α-diversity and β-diversity across lactation stages. The predominant bacterial genera-Streptococcus, Pseudomonas, and Staphylococcus-showed distinct bimodal temporal patterns. Correlation analyses revealed that tetratose and sialylated HMOs were positively associated with Bacteroides abundance, while multiple HMOs negatively correlated with Streptococcus. These findings underscore the complex interactions between breast milk oligosaccharides and microbial communities, highlighting their potential implications for infant gut health. Further research is needed to explore the clinical significance of these transformations and their role in shaping the early-life microbiome. PRACTICAL APPLICATIONS: This study shows how breast milk changes over time, with certain sugars (HMOs) decreasing and others shifting, while beneficial bacteria also fluctuate. These changes may influence an infant's gut health and development. Understanding these patterns can help improve infant nutrition, guide breastfeeding recommendations, and support the design of better infant formulas or probiotics.
Keywords: human‐milk microbiota; human‐milk oligosaccharides; lactation.
© 2025 Institute of Food Technologists.
Similar articles
-
1H Nuclear Magnetic Resonance-Based Metabolomic Profiling and Comparison of Human Milk across Different Lactation Stages in Secretors and Nonsecretors: A Study of Chinese Lactating Women.J Nutr. 2025 Jan;155(1):78-86. doi: 10.1016/j.tjnut.2024.10.050. Epub 2024 Nov 2. J Nutr. 2025. PMID: 39491676
-
Early life bifidobacterial mother-infant transmission: greater contribution from the infant gut to human milk revealed by microbiomic and culture-based methods.mSystems. 2025 Jul 22;10(7):e0048025. doi: 10.1128/msystems.00480-25. Epub 2025 Jun 25. mSystems. 2025. PMID: 40558046 Free PMC article.
-
Human milk oligosaccharide metabolism and antibiotic resistance in early gut colonizers: insights from bifidobacteria and lactobacilli in the maternal-infant microbiome.Gut Microbes. 2025 Dec;17(1):2501192. doi: 10.1080/19490976.2025.2501192. Epub 2025 May 9. Gut Microbes. 2025. PMID: 40340669 Free PMC article.
-
Transfer of Bacteria From Mothers to Infants Through Breast Milk: A Systematic Review.Pediatr Infect Dis J. 2025 Mar 4;44(8):804-812. doi: 10.1097/INF.0000000000004769. Pediatr Infect Dis J. 2025. PMID: 40063731
-
Combined hormonal versus nonhormonal versus progestin-only contraception in lactation.Cochrane Database Syst Rev. 2015 Mar 20;2015(3):CD003988. doi: 10.1002/14651858.CD003988.pub2. Cochrane Database Syst Rev. 2015. PMID: 25793657 Free PMC article.
References
-
- Ackerman, D. L., K. M. Craft, R. S. Doster et al. 2018. “Antimicrobial and Antibiofilm Activity of Human Milk Oligosaccharides Against Streptococcus agalactiae, Staphylococcus aureus, and Acinetobacter baumannii.” ACS Infectious Diseases 4, no. 3: 315–324. https://doi.org/10.1021/acsinfecdis.7b00183.
-
- Austin, S., C. A. De Castro, N. Sprenger et al. 2019. “Human Milk Oligosaccharides in the Milk of Mothers Delivering Term Versus Preterm Infants.” Nutrients 11, no. 6: 1282. https://doi.org/10.3390/nu11061282.
-
- Bode, L. 2018. “Human Milk Oligosaccharides in the Prevention of Necrotizing Enterocolitis: A Journey from in Vitro and in Vivo Models to Mother‐Infant Cohort Studies.” Frontiers in Pediatrics 6: 385. https://doi.org/10.3389/fped.2018.00385.
-
- Boix‐Amoros, A., M. C. Collado, and A. Mira 2016. “Relationship Between Milk Microbiota, Bacterial Load, Macronutrients, and Human Cells During Lactation.” Frontiers in Microbiology 7: 492. https://doi.org/10.3389/fmicb.2016.00492.
-
- Craft, K. M., H. C. Thomas, and S. D. Townsend 2018. “Interrogation of Human Milk Oligosaccharide Fucosylation Patterns for Antimicrobial and Antibiofilm Trends in Group B Streptococcus.” ACS Infectious Diseases 4, no. 12: 1755–1765. https://doi.org/10.1021/acsinfecdis.8b00234.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources